The Role of Personalization in the User Experience, Preferences and Engagement with Virtual Reality Environments for Relaxation
Overview
Public Health
Authors
Affiliations
Methods: A non-clinical sample of 20 individuals participated in exposure to a supportive body-scan-guided relaxation VRE. In the personalized conditions, the participants had the option of choosing the context (e.g., sea, mountain, or countryside) and including in the scenario different types of sounds, visual elements, and changing the time of day and weather. In the standard conditions, individuals were exposed to a relaxing VRE, but they could choose neither the context nor the auditory and visual elements. The order of presentation of the personalized vs non-personalized environments was randomized. Measures regarding relaxation, state-anxiety perceived levels, VRE-related symptoms, the usability of the Virtual Reality (VR) setting, sense of presence, pleasure, activation, engagement, and level of immersion experienced were collected before and after exposure to the VR environments.
Results: Findings showed that personalized VREs were preferred by users. Participants generally preferred to experience a greater immersivity, pleasure, engagement, and relaxation in the personalized virtual settings.
Conclusion: The study further confirms the role of personalization as a component positively contributing to relaxation and engagement. Future research may further assess this effect in the context of large-scale controlled studies involving clinical and non-clinical populations.
Buche H, Michel A, Anders R, Blanc N Cancers (Basel). 2025; 17(5).
PMID: 40075687 PMC: 11899700. DOI: 10.3390/cancers17050840.
Designing a Smartphone-Based Virtual Reality App for Relaxation: Qualitative Crossover Study.
Verstegen A, Van Daele T, Bonroy B, Debard G, Sels R, van Loo M JMIR Form Res. 2025; 9:e62663.
PMID: 39946693 PMC: 11888098. DOI: 10.2196/62663.
Merrill J, Gebru N, Peterson R, Lopez G, Lau-Barraco C, Barnett N Alcohol Clin Exp Res (Hoboken). 2024; 48(10):1951-1964.
PMID: 39306826 PMC: 11636549. DOI: 10.1111/acer.15424.
Jehl N, Hess C, Choate E, Nguyen H, Yang Y, Simons L J Pediatr Psychol. 2024; 50(1):76-85.
PMID: 39110918 PMC: 11753872. DOI: 10.1093/jpepsy/jsae056.
McAnirlin O, Thrift J, Li F, Pope J, Browning M, Moutogiannis P Contemp Clin Trials Commun. 2024; 40:101318.
PMID: 39045392 PMC: 11263497. DOI: 10.1016/j.conctc.2024.101318.